• Corazza M, la Malfa W, Lombardi A, Maranini C, Virgili A. Role of allergic contact dermatitis in rosacea. Contact Dermatitis. 1997;37:40-41.

  • Ellis, C.N., M.D., and M.A. Strawiski, M.D. Symposium on the Treatment of Skin: The Treatment of Perioral Dermatitis, Acne Rosacea, and Seborrheic Dermatitis. Medical Clinics of North America. 66:4, pages 819-830, 1982.

  • Kanerva L, Alanko K, Jolanki R, Estlander T. Laboratory assistant's occupational allergic airborne contact dermatitis from nickel presenting as rosacea. Eur J Dermatol. 1999;9:397-398.

  • Ljubojeviae S, Basta-Juzbasiae A, Lipozeneiae J. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. J Eur Acad Dermatol Venereol. 2002;16:121-126.

  • Richardson DP. Seborrheic dermatitis and rosacea. Compr Ther. 1981;7:57-60.

  • Sneddon IB. The treatment of steroid-induced rosacea and perioral dermatitis. Dermatologica. 1976;152 Suppl 1:231-237.

  • Steigleder GK, Strempel A. [Rosacea-like dermatitis of the face. "Perioral dermatitis"]. Hautarzt. 1969;20:288.

  • Tomita Y, Tagami H. Steroid-withdrawal rosacea-like dermatitis. J Dermatol. 1989;16:335-337.

  • Urabe H, Koda H. Perioral dermatitis and rosacea-like dermatitis: clinical features and treatment. Dermatologica. 1976;152 Suppl 1:155-160.

  • Urabe H. [Perioral dermatitis (rosacea-like dermatitis)--adverse effects of externally applied steroid preparations]. Nippon Rinsho. 1978;Suppl:2400-2401.

  • Weber G. Rosacea-like dermatitis: contraindication or intolerance reaction to strong steroids. Br J Dermatol. 1972;86:253-259.

  • Clark RAF, Nicol N, Adinoff AD: Atopic dermatitis. In: Sams WM, ed. Principles and Practice of Dermatology. New York: Churchill Livingstone; 1990: 365-380.

  • Landow K: Atopic dermatitis. Current concepts support old therapies and spur new ones. Postgrad Med 1997 Mar; 101(3): 101-4, 107-8, 111-2 passim.

  • Rudikoff D, Lebwohl M: Atopic dermatitis. Lancet 1998 Jun 6; 351(9117): 1715-21.

  • Schultz Larsen F: Atopic dermatitis: an increasing problem. Pediatr Allergy Immunol 1996; 7(9 Suppl): 51-3.

  • Leung DYM, Rhodes AR, Geha RS, et al. Atopic dermatitis. In: Fitzpatrick TR, et al, eds. Dermatology in general medicine. Fourth Edition. New York: McGraw-Hill, 1993:1543.

  • Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302.

  • Leiferman KM, Ackerman SJ, Sampson HA, et al. Dermal deposition of eosinophil granule major basic protein in atopic dermatitis. N Engl J Med 1985;313:282.

  • Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128.

  • Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44.

  • Hanifin JM, Cooper KD. Atopy and atopic dermatitis. J Am Acad Dermatol 1986;15:703.

  • Rystedt I. Work-related hand eczema in atopics. Contact Dermatitis 1985;12:164.

  • Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994;94:870.

  • Leung DYM. Role of IgE in atopic dermatitis. Curr Opinion Immunol 1993;5:956.

  • Mudde GC, Van Reijsen FC, Boland GJ, et al. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990;69:335.

  • Chan SC, Kim JW, Henderson WR, et al. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993;151:3345.

  • Boguniewicz M, Leung DYM. Management of atopic dermatitis. In: Leung DYM, ed. Atopic dermatitis: from pathogenesis to treatment. Austin: R/tG Landes Co 1996:185.

  • Sampson HA, Albergo R. Comparison of results of prick skin tests, RAST, and double-blind placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984;74:26.

  • Jones SM, Sampson HA. The role of allergens in atopic dermatitis. In: Leung DYM, ed. atopic dermatitis: from pathogenesis to treatment. Austin: R/tG Landes Co, 1996:41.

  • Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients. J Pediatr 1985;107:669.

  • Adinoff AD, Tellez P, Clark RAF. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol. 1988;81:736.

  • Norris P, Schofield O, Camp R. A study of the role of house dust mite in atopic dermatitis. Br J Dermatol 1988;118:435.

  • Hanifin JM. Atopic dermatitis: new therapeutic considerations. J Am Acad Dermatol 1991;24:1097.

  • Nassif A, Chan SC, Storrs FJ, et al. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol 1994;130:1402.

  • Sampson HA. The role of food allergy and mediator release in atopic dermatitis. J Allergy Clin Immunol 1988;81:635.

  • Sampson HA, Broadbent KR, Bernhisel-Broadbent J. 'Spontaneous' basophil histamine release and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989;321:228.

  • Platts-Mills TAE, Mitchell EB, Rowntree S, et al. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 1983;8:233.

  • Sanda T, Yasue T, Oohashi M, et al. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653.

  • White A, Horne DJ, Varigos GA. Psychological profile of the atopic eczema patient. Australas J Dermatol 1990;31:13.

  • Scheich G, Florin I, Rudolph R, et al. Personality characteristics and serum IgE level in patients with atopic dermatitis. J Psychosom Res 1993;37:637.

  • Noren P, Melin L. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis. Br J Dermatol 1989;121:359.

  • Melin L, Frederiksen T, Noren P, et al. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol 1986;115:467.

  • Horne DJ, White AE, Varigos GA. A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol 1989;62:241.

  • Haynes SN, Wilson CC, Jaffe PG, et al. Biofeedback treatment of atopic dermatitis: controlled case studies of eight cases. Biofeedback Self Regul 1979;4:195.

  • Hauser C, Prins C, Lacour M. The role of infectious agents. In: Leung DYM, ed. Atopic dermatitis: from pathogenesis to treatment. Austin: R/tG Landes Co, 1996:67.

  • Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189.

  • Novelli VM, Atherton DJ, Marshall WC. Eczema herpeticum. Clinical and laboratory features. Clin Pediatr 1988;27:231.

  • Bork K, Brauninger W. Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 1988;19:1024.

  • Kieffer M, Bergbrant IM, Faergemann J, et al. Immune reactions to Pityro-sporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 1990;22:739.

  • Broberg A, Faergemann J, Johansson S, et al. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol 1992;72:187.

  • Wilson BB, Deuell B, Mills TA. Atopic dermatitis associated with dermatophyte infection and Trichophyton hypersensitivity. Cutis 1993;51:191.

  • Clemmensen OJ, Hjorth N. Treatment of dermatitis of the head and neck with ketoconazole in patients with type I hypersensitivity for Pityrosporum orbiculare. Semin Dermatol 1983;2:26.

  • Doherty V, Sylvester DGH, Kennedy CTC, et al. Treatment of itching in atopic eczema with antihistamines with a low sedative profile. Br Med J 1989;298:96.

  • Berth-Jones J, Graham-Brown RAC. Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989;121:635.

  • Langeland T, Fagertun HE, Larsen S. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study. Allergy 1994;49:22.

  • Hannuksela M, Kalimo K, Lammintausta K, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis. Ann Allergy 1993;70:127.

  • Drake LA, Fallon JD, Sober A, et al. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 1994;31:613.

  • Shelley WB, Shelley ED, Talanin NY. Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream. J Am Acad Dermatol 1996;34:143.

  • Nicol NH. Atopic dermatitis: the (wet) wrap-up. Am J Nurs 1987;87:1560.

  • George SA, Bilsland DJ, Johnson BE, et al. Narrow band (TL-01) UVB air conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993;128:49.

  • Midelfart K, Stenvold SE. Voloden G. Combined UVB and UVA phototherapy of atopic eczema. Dermatologica 1985;171:95.

  • Krutmann J, Czech W, Giepgen T, et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992;26:225.

  • Krutmann J, Schopf E. High-dose UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:120.

  • Morison WL, Parrish JA, Fitzpatrick TB. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol 1978;98:25.

  • Honig B, Morison WL, Karp D. Photochemotherapy beyond psoriasis. J Am Acad Dermatol 1994;31:775.

  • Fuenmayer M, DiPrisco MC, Champion RH. Specific hyposensitization in atopic dermatitis. Br J Dermatol 1979;101:697.

  • Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992;22:440.

  • Kaufman HS, Roth HL. Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo-controlled study. Ann Allergy 1974;32:321.

  • Zachariae H, Cramers M, Herlin T, et al. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1985;114:48.

  • Jacquemin MG, Machiels JJ, Lebrun PM, et al. Successful treatment of atopic dermatitis with complexes of allergen and specific antibodies. Lancet 1990;335:1468.

  • Leroy BP, Boden G, Lachapelle JM, et al. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993;28:232.

  • Leroy BP, Jacquemin MG, Lachapelle JM, et al. Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab`)2 fragments of specific antibodies. Br J Dermatol 1995;132:599.

  • Boguniewicz M, Jaffe HS, Izu A, et al. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990;88:365.

  • Hanifin JM, Schneider LC, Leung DYM, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189.

  • Reinhold U, Kukel S, Brzoska J, et al. Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 1993;29:58.

  • Torrelo A, Harto A, Sendagorta E, et al. Interferon-alpha therapy in atopic dermatitis. Acta Derm Venereol 1992;72:370.

  • Michils A, Farber CM, Van Vooren JP, et al. Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis. Br J Dermatol 1994;130:134.

  • Jullien D, Nicolas JF, Frappaz A, et al. Alpha interferon treatment in atopic dermatitis. Acta Derm Venereol 1993;73:130.

  • Paukkonen K, Fraki J, Horsmanheimo M. Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis. Acta Derm Venereol 1993;73:141.

  • Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe atopic dermatitis. Lancet 1991;338:137.

  • Van Joost Th, Kozel MMA, Tank B, et al. Cyclosporine in atopic dermatitis: modulation in the expression of immunologic markers in lesional skin. J Am Acad Dermatol 1992;27:922.

  • Wahlgren CF, Scheynius A, Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol 1990;70:323.

  • van Joost T, Heule F, Korstanje M, et al. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994;130:634.

  • de Prost Y, Bodemer C, Teillac D. Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:136.

  • De Rie MA, Meinardi MHM, Bos JD. Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis. Acta Derm Venereol 1991;71:452.

  • Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994;344:24.

  • Sawai T, Ikai K, Uehara M. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leukocytes from children with atopic dermatitis. Br J Dermatol 1995;132:22.

  • Lester MR, Gately M, Trumble A, Leung DYM. Effects of IL-12 and staphylococcal toxic shock syndrome toxin-1 on the interferon-gamma response in atopic dermatitis. J Immunol 1995;154:6174.

  • Hanifin JM, Chan SC, Cheng JB, et al. Type 4 phosphodieserase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 1996;107:51.

  • Melnik B, Plewig G. Are disturbances of |gq-6-fatty acid metabolism involved in the pathogenesis of atopic dermatitis? Acta Derm Venereol (Stockh) 1992;176:77.

  • Bjorneboe A, Soyland E, Bjorneboe GE, et al. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol 1987;117:463.

  • Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol 1994;130:757.

  • Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557.

  • Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992;126:179.

  • Sheehan MP, Rustin MH, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992;340:13.

  • Harper J. Traditional Chinese medicine for eczema. Br Med J 1994;308:489.

  • Davis EG, Pollock I, Steel HM. Chinese herbs for eczema. Lancet 1990;336:177

  • Camp RD. Psoriasis. In: Rook A, Wilkinson DS, Ebling FJ, eds. Textbook of dermatology. 5th ed. Oxford: Blackwell Scientific, 1992:1391-458.

  • Weinstein GD, Van Scott EJ. Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J Invest Dermatol 1965;45:257-62.

  • Katz HI, Hien NT, Prawer SE, Mastbaum LI, Mooney JJ, Samson CR. Superpotent topical steroid treatment of psoriasis vulgaris.clinical efficacy and adrenal function. J Am Acad Dermatol 1987;16: 804-11.

  • Runne U, Kunze J. Short-duration ("minutes") therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 1982;106:135-9.

  • Marsden JR, Coburn PR, Marks J, Shuster S. Measurement of the response of psoriasis to short-term application of anthralin. Br J Dermatol 1983;109: 209-18.

  • Lowe NJ, Ashton RE, Koudsi H, Verschoore M, Schaefer H. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. J Am Acad Dermatol 1984;10:69-72.

  • Dodd WA. Tars: their role in the treatment of psoriasis. Dermatol Clin 1993;11:131-5.

  • Stewart AF, Battaglini-Sabetta J, Millstone L. Hypocalcemia-induced pustular psoriasis of von Zumbusch. New experiences with an old syndrome. Ann Intern Med 1984;100:677-80.

  • Morimoto S, Kumahara Y. A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ 1985;35:51-4.

  • Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larko O, et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991;337:193-6 [Published erratum in Lancet 1991;337:988].

  • Cunliffe WJ, Berth-Jones J, Claudy A, Fairiss G, Goldin D, Gratton D, et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992;26(5 Pt 1):736-43.

  • Berth-Jones J, Chu AC, Dodd WA, Ganpule M, Griffiths WA, Haydey RP, et al. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992;127:266-71.

  • Tham SN, Lun KC, Cheong WK. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. Br J Dermatol 1994;131:673-7.

  • Ramsay CA. Management of psoriasis with calcipotriol used as monotherapy. J Am Acad Dermatol 1997;37(3 Pt 2):S53-4.

  • Kirsner RS, Federman D. Treatment of psoriasis: role of calcipotriene. Am Fam Physician 1995;52: 237-40.

  • Weinstein GD, Krueger GG, Lowe NJ, Duvic M, Friedman DJ, Jegasothy BV, et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997;37:85-92.

    This page lists references for further reading about dermatitis, including medications used in the treatment of dermatitis and other skin conditions that co-exist with dermatitis, such as rosacea, acne, eczema, and psoriasis.

    Latest headlines from Dermatitis-Ltd International News

    Causes of Psoriasis

    Researchers believe the immune system sends faulty signals that speed up the growth cycle in skin cells. Certain people carry genes that make them more likely to develop psoriasis, but not everyone with these genes develops psoriasis. Instead, a “trigger” makes the psoriasis appear in those who have these genes. Also, some triggers may work [...] (read more)

    Recent articles:

    • References

    1. Camisa, Charles, M.D. Psoriasis, 1994, pp.7-75.

    2. Hall, John C., M.D.  Sauer's Manual of Skin Diseases, 8th Edition, 2000, pp.79-134.

    3. Hunter, J.A.A., M.D., J.A. Savin, M.D., and M.V. Dahl, M.D. Clinical Dermatology, 1989, pp.76-77.

    4. Mackie, Rona M.  Clinical Dermatology:  An Illustrated Textbook, 2nd Edition, 1987, pp.36-37,77,88.

    5. Pillsbury, Donald M., M.D., Walter B. Shelley, M.D., and Albert M. Kligman, M.D. Dermatology, 1956, p.729

    6. Rietschel, Robert L., M.D., Luis Conde-Salazar, M.D., An Goosens, M.D., and Niels K. Veien, M.D. Atlas of Contact Dermatitis, 1999, p.215.

    7. Dermatology Times, Vol.19 Issue 10.  October:  p.12, 1998.

    8. Whitman, L.R. and McGibbon, D.H. The Management of Psoriasis. International Journal of Clinical Practice. October: pp.487-491, 1998.

    9. Nicksin, Carole. "The heartbreak of ... psoriasis is a traumatic disease, but now there's hope for sufferers". Vegetarian Times, Issue 272. April: pp.24-27, 2000.

    10. Psoriasis Q & A. National Psoriasis Foundation, Inc., Portland, Oregon, 1998.

    11. Clear Up Psoriasis. ICN Pharmaceuticals, Inc, 1998.

    12. Rosacea-like dermatitis. Br Med J. 1969;3:545-546.

    13. Barankin B, Guenther L. Rosacea and atopic dermatitis. Two common oculocutaneous disorders. Can Fam Physician. 2002;48:721-724.

    14. Bardazzi F, Manuzzi P, Riguzzi G, Veronesi S. Contact dermatitis with rosacea. Contact Dermatitis. 1987;16:298.

    15. Boni R. [Rosacea, acne and other diseases of the seborrheic spectrum]. Schweiz Rundsch Med Prax. 2000;89:566-570.

    Psoriasis Application Advantages Lifestyle
    Order Progress Follow Up Glossary References Home

    Dermatitis-Ltd International News

    Copyright © 1998-2007 Bass & Boney, Inc.